CliffBio
small molecule

ACULAR LS

KETOROLAC TROMETHAMINE

Loss of exclusivityNovember 2027latest FDA-listed patent expiry
CompanyAbbVie Inc. →View the full company profile on CliffBio

Drug detail

Brand nameACULAR LS
Active ingredientKETOROLAC TROMETHAMINE
Strength0.4%
Dosage formSOLUTION/DROPS
RouteOPHTHALMIC
ModalitySmall molecule
FDA approvalMay 2003
Marketing statusRX

Listed patents

PatentExpiresType
8008338*PEDNovember 2027—
8008338May 2027substance, product

More from AbbVie Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

ACULAR LS patent cliff — loss of exclusivity November 2027 | CliffBio